Pfizer and Novo Nordisk are in a takeover clash over the obesity biotech Metsera, while some House Republicans warm to ...
Investor's Business Daily on MSN
Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled
Novo Nordisk stock skidded early Wednesday after the Wegovy and Ozempic maker cut its sales outlook for the third time this ...
Yahoo Finance Senior Reporter Allie Canal takes a closer look at some of Wednesday's trending tickers, including Novo Nordisk ...
Investors got to hear Novo Nordisk’s side of the Metsera bidding war drama for the first time on Wednesday, as the company ...
The boss of the Wegovy firm linked its reduced guidance to the market for weight-loss treatments being ‘more competitive than ever’.
Eli Lilly stock recently achieved a significant milestone, reaching a 52-week high of $935.68, with shares now trading at $935.97. This marks a notable achievement for the pharmaceutical giant, ...
Heineken’s Harold van den Broek said beer demand remains soft, Tesla’s Vaibhav Taneja flagged tariff drag, Brian Dykes talked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback